SensorFM: Towards a general intelligence and interface for wearable health data
Generative AI
More from the blog
3 Questions: What is the best path forward for AI in academia?
MIT Statistics and Data Science Center Director Alexander (Sasha) Rakhlin shares important considerations for departments and institutions.
Using AI to mitigate the growing environmental threat of data centers
By rethinking how large cloud computing systems operate, Associate Professor Christina Delimitrou seeks to make data centers more energy efficient.
Chris Bourg named vice provost and Barbara K. Ostrom (1978) Director of the MIT Libraries
As director, Bourg has focused on digital access, open and equitable scholarly publishing, and expanded support for data-intensive research.
Unlocking Earth AI’s planetary geospatial foundation models for global public health
Earth AI
Related papers
A Multiple Case Study of Artificial Intelligent System Development in Industry
This investigation revealed different types of AI systems and different AI development approaches, but it is common that business opportunities involving with AI systems are not validated and there is lack of business-driven metrics that guide the development ofAI systems.
Experimenting with Multi-Agent Software Development: Towards a Unified Platform
A unified platform that utilizes multiple artificial intelligence agents to automate the process of transforming user requirements into well-organized deliverables, including user stories, prioritization, and UML sequence diagrams, along with the modular approach to APIs, unit tests, and end-to-end tests.
Bridging Humans and LLMs: Investigating Human-AI Collaboration in Multi-agent Requirements Analysis for Organizational AI Adoption
LLM-based multi-agent systems can support strategic AI planning by enabling iterative refinement with human experts by supporting structured and collaborative Requirements Engineering processes for AI adoption planning.
Computational and AI-Driven Ecosystem for Structure-Based Covalent Drug Discovery.
This Account describes a computational and AI-driven ecosystem for structure-based covalent drug discovery and dives into a suite of cutting-edge, AI-driven computational methods, exploring the potential of deep learning in tasks such as molecular docking, covalent binding site prediction, and lead optimization.